As per the latest market research conducted by FMI, the global radiotherapy patient positioning accessories market is expected to record a CAGR of 4.8% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 619.5 million. By 2033, the valuation is anticipated to reach US$ 993.6 million.
Radiotherapy patient positioning accessories are the tools used to accurately position and immobilize patients undergoing radiation therapy. These positioning accessories help to ensure that the radiation dose is delivered precisely to the tumor, while also protecting healthy tissue from damage.
Significant Growth Aspects:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The radiotherapy patient positioning accessories market is expected to experience a healthy growth rate in the coming years. However, there are certain factors that can impede this growth and limit the potential of the market. These factors include the high cost of radiotherapy equipment, lack of skilled professionals, and stringent government regulations. Also, the lack of awareness among healthcare personnel about the latest advancements in radiotherapy technology can also restrain the market growth.
Attributes | Value |
---|---|
Radiotherapy Patient Positioning Accessories Value (2022) | US$ 588.8 million |
Radiotherapy Patient Positioning Accessories Market Expected Value (2023) | US$ 619.5 million |
Radiotherapy Patient Positioning Accessories Market Forecast Value (2033) | US$ 993.6 million |
Radiotherapy Patient Positioning Accessories Market Expected CAGR (2023 to 2033) | 4.8% |
Particulars | Details |
---|---|
H1, 2021 | 4.95% |
H1, 2022 Projected | 5.09% |
H1, 2022 Outlook | 4.99% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (+) 04 ↑ |
The global radiotherapy patient positioning accessories market is subject to market dynamics associated with macroeconomic and industry standards such as regulatory guidelines and product quality and safety assessment.
According to Future Market Insights' analysis, the global radiotherapy patient positioning accessories market expects to surge in value by 04 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to the H1-2022 Projected value, the market during the H1-2022 outlook period showed a dip of 10 BPS.
The growth of intensity-modulated radiation treatment, stereotactic body radiotherapy, and adaptive radiotherapy has resulted in an increase in the necessity for effective patient positioning, which is correlated with an increase in the observed BPS values.
The usage of immobilization devices during radiation for improved procedural outcomes is one of the significant industry breakthroughs.
However, as a result of the global lockdown measures implemented during the COVID-19 pandemic's onset, the reported reduction in BPS is linked to a relative decline in medical diagnostic and imaging operations. Hence, lower procedure rates have helped to bring down BPS levels.
The demand in the global radiotherapy patient positioning accessories market recorded a CAGR of 4.6% from 2018 to 2022. The sales of radiotherapy patient positioning accessories are estimated to grow by 1.6x between 2023 and 2033, reveals FMI.
A non-invasive cancer treatment method known as radiation therapy employs high-intensity waves or particles to eliminate cancerous cells. Radiation patient positioning accessories are widely used to help patients keep their position comfortably since it is important for patients to retain their specific position during therapy to avoid issues. This is helping the market to expand.
Due to radiation therapy's fewer side effects and capacity to stop the regrowth of cancer cells, more and more people are switching from various cancer therapies like chemotherapy and surgery. This is driving up demand for equipment for patient positioning during radiation.
As per the latest market research conducted by FMI, the global radiotherapy patient positioning accessories market is expected to record a CAGR of 4.8% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 619.5 million. By 2033, the valuation is anticipated to reach US$ 993.6 million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
A major growth in the burden of cancer is being noticed over the previous few years, mainly to the growing alcohol intake, smoking, and others. For instance, the World Health Organization (WHO) estimates that more than 10 million new instances of cancer would be diagnosed worldwide in 2020.
To reduce the incidence and cancer-related deaths, governments in many nations are increasingly launching several cancer detection and treatment efforts. In order to encourage early cancer diagnosis, the Government of India announced the formation of the National Programme for Prevention & Control of Cancer, Diabetes, Cardiovascular diseases & Stroke (NPCDCS).
Many such initiatives in the United States, Germany, the United Kingdom, and China have significantly raised the rate of cancer diagnoses, spurring a rise in the use of cutting-edge cancer therapies like radiation. In the upcoming years, there is likely to be a high need for accessories for radiotherapy patient positioning as a result of this.
To Increase Sales of Radiotherapy Immobilization Devices, Patients' Preferences are being Shifted Towards Non-Invasive Treatments.
By 2033, the United Kingdom is anticipated to contribute significantly to sales in the Europe market, according to FMI, and is predicted to record a CAGR of 4.2% over the forecast period.
Due to its non-invasive nature and lack of side effects when compared to other therapies, advanced cancer treatments like radiation are becoming extremely popular throughout the United Kingdom, hence it is predicted that rising rates of obesity, smoking, alcoholism, nicotine addiction, and cancer is likely to increase demand for radiation immobilization tools such as locating & indexing bars, couch top & overlays, and others.
Favorable Government Early Diagnose Efforts to Drive Demand for Radiotherapy Patient Positioning Accessories
FMI estimates that the United States is likely to continue dominating the North American radiotherapy patient positioning accessories market over the forecast period. The market in the United States is expected to record a CAGR of 4.2% over the forecast period.
The government in the countries is launching several programs to reduce the fatalities brought on by cancer, such as putting up free screening camps, in response to the rising incidence of cancer and increasing awareness of the advantages of an early cancer diagnosis. Due to this, there is a sharp increase in demand for radiation patient positioning accessories across the nation's installed base of radiotherapy systems.
Growth Outlook of Country-wise Insights:
Country | United States |
---|---|
CAGR (2018 to 2022) | 4.3% |
CAGR (2023 to 2033) | 4.2% |
Valuation (2033) | US$ 273.7 million |
Country | United Kingdom |
---|---|
CAGR (2018 to 2022) | 4.4% |
CAGR (2023 to 2033) | 4.2% |
Valuation (2033) | US$ 39.9 million |
Country | China |
---|---|
CAGR (2018 to 2022) | 7.9% |
CAGR (2023 to 2033) | 9.3% |
Valuation (2033) | US$ 94.6 million |
Country | Germany |
---|---|
CAGR (2018 to 2022) | 5.4% |
CAGR (2023 to 2033) | 5.1% |
Valuation (2033) | US$ 53.4 million |
Increasing Two-Step Radiation Treatment Adoption to Meet Need for Radiotherapy Patient Positioning Accessories
By 2023, sales of radiotherapy patient positioning accessories are expected to be dominated by the couch tops & overlays category, with more than 1/5 of the market, according to Future Market Insights.
In two-step radiation therapy, couch tops & overlays are frequently employed in diagnosis and imaging equipment, such as CT scans, to let patients relax in a specific position comfortably. As a result, the segment is growing because of the increasing use of two-step radiation therapy for accurately targeting malignant areas.
Increasing Medical Travel to Boost Sales of Radiation Treatment Immobilization Equipment
On the basis of end user, the global radiotherapy patient positioning accessories market is segmented into hospitals, radiation/proton therapy centers, and cancer research institutes. FMI states that the hospital segment is estimated to record a CAGR of 3.9% over the forecast period.
Radiation therapy immobilization device sales are being supported by rising medical tourism, which is increasing patient volume in cancer treatment centers. The segment's expansion is primarily facilitated by the presence of competent professionals, cutting-edge cancer diagnosis and treatment technology, and benevolent reimbursement policies in hospitals.
Leading companies in the global market for radiotherapy patient positioning accessories are utilizing inorganic tactics and forming strategic alliances, partnerships, mergers, and acquisitions with other market participants to broaden their reach internationally. For example,
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | US$ million for Value |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa |
Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Türkiye, Northern Africa, South Africa |
Key Segments Covered | Product Type, End User, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The market is projected to secure a valuation of US$ 619.5 million in 2023.
From 2018 to 2022, the market registered a CAGR of 4.6%.
The market is expected to reach US$ 993.6 million in 2033.
Shift in patients' preferences toward non-invasive treatments fueling the United Kingdom Market.
CDR Systems, CIVCO Radiation, Orfit Industries N.V. are the leading industry players.
1. Executive Summary | Radiotherapy Patient Positioning Accessories Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Couch Tops & Overlays
5.3.1.1. Couch Top with Moving Rails
5.3.1.2. Couch Tops without Moving Rails
5.3.1.3. Inserts
5.3.1.4. CT Overlays
5.3.1.5. MR Overlays
5.3.2. Thermoplastic Masks & Sheets
5.3.2.1. Head Masks
5.3.2.2. Head and Shoulder Masks
5.3.2.3. Breast and Pelvic Sheets
5.3.3. Markers
5.3.3.1. Fiducial Markers
5.3.3.2. Vaginal Markers
5.3.3.3. Rectal Markers
5.3.4. Immobilization System
5.3.5. Head Rest
5.3.6. Cushions
5.3.7. Spacers & Wedges
5.3.8. Arm & Wrist Supports
5.3.9. Locating & Indexing Bar
5.3.10. Safety drapes
5.3.11. Boot pads
5.3.12. Other products
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Surgeries
6.3.2. Diagnostic & Imaging
6.3.3. Cancer Therapy
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Radiation/Proton Therapy Centres
7.3.3. Cancer Research Institutes
7.3.4. Ambulatory Surgical Centres
7.3.5. Speciality Clinics
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By End User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Bionix Radiation Therapy
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. CDR Systems
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. CIVCO Radiation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Orfit Industries N.V.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. IZI Medical Products
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Klarity Medical Products
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Best Medical International Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Eckert & Ziegler BEBIG
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Qfix
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Elekta AB
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports